Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study-Reference-Cited by-同舟云学术

Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study

Published:2017-12 Issue:12 Volume:25 Page:1952-1961
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Wang S.X.,Abramson S.B.,Attur M.,Karsdal M.A.,Preston R.A.,Lozada C.J.,Kosloski M.P.,Hong F.,Jiang P.,Saltarelli M.J.,Hendrickson B.A.,Medema J.K.

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference44 articles.

1. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis;Kapoor;Nat Rev Rheumatol,2011

2. Cytokines and pain;de Oliveira;Rev Bras Anestesiol,2011

3. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis;Dayer;Rheumatology (Oxford),2003

4. Mechanisms of NOD-like receptor-associated inflammasome activation;Wen;Immunity,2013

5. Understanding the mechanism of IL-1beta secretion;Lopez-Castejon;Cytokine Growth Factor Rev,2011

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials;Clinical Rheumatology;2024-07-03

2. Efficacy of Anti-Interleukin-1 Therapeutics in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials from the Years 2000 to 2023;Journal of Clinical Medicine;2024-05-13

3. Association of biochemical markers with bone marrow lesion changes on imaging—data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium;Arthritis Research & Therapy;2024-01-18

4. Pathological tissue formation and degradation biomarkers correlate with patient reported pain outcomes: an explorative study;Osteoarthritis and Cartilage Open;2023-09

5. Assessment of the synergistic anti-inflammatory effect of naringin/sulindac for the treatment of osteoarthritis: in vitro and in vivo;Advances in Traditional Medicine;2023-07-25